Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
TOBETA-XL; TOPRELOC-XL (Pharmacor Pty Ltd)
Product name
TOBETA-XL; TOPRELOC-XL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
190 (255 working days)
Active ingredients
metoprolol/metoprolol succinate
Registration type
New generic medicine
Indication
TOBETA-XL; TOPRELOC-XL (modified release tablet) is indicated as a treatment for stable, chronic heart failure as an adjunct to other heart failure therapy.